Wave Life Sciences Ltd. [WVE] stock prices are up 3.37% to $8.29 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The WVE shares have gain 45.95% over the last week, with a monthly amount glided 48.30%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, B. Riley Securities started tracking the stock with Buy rating on September 19, 2024, and set its price target to $11. On September 09, 2024, JP Morgan initiated with a Overweight rating and assigned a price target of $10 on the stock. Wells Fargo started tracking the stock assigning a Overweight rating and suggested a price target of $11 on May 15, 2024. Leerink Partners upgraded its rating to a Outperform and raised its price target to $12 on December 19, 2023. Raymond James started tracking with a Outperform rating for this stock on July 05, 2023, and assigned it a price target of $7. In a note dated May 24, 2023, Jefferies downgraded an Hold rating on this stock and revised its target price from $7 to $5.
The stock price of Wave Life Sciences Ltd. [WVE] has been fluctuating between $3.50 and $9.92 over the past year. Currently, Wall Street analysts expect the stock to reach $14.5 within the next 12 months. Wave Life Sciences Ltd. [NASDAQ: WVE] shares were valued at $8.29 at the most recent close of the market. An investor can expect a potential return of 74.91% based on the average WVE price forecast.
Analyzing the WVE fundamentals
The Wave Life Sciences Ltd. [NASDAQ:WVE] reported sales of 110.50M for trailing twelve months, representing a drop of -10.92%. Gross Profit Margin for this corporation currently stands at 0.92% with Operating Profit Margin at -0.76%, Pretax Profit Margin comes in at -0.67%, and Net Profit Margin reading is -0.67%. To continue investigating profitability, this company’s Return on Assets is posted at -0.35, Equity is -6.58 and Total Capital is -2.34. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of6.57.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.11 points at the first support level, and at 7.94 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.45, and for the 2nd resistance point, it is at 8.62.
Ratios To Look Out For
It’s worth pointing out that Wave Life Sciences Ltd. [NASDAQ:WVE]’s Current Ratio is 0.99. In addition, the Quick Ratio stands at 0.99 and the Cash Ratio stands at 0.89. Considering the valuation of this stock, the price to sales ratio is 9.61.
Transactions by insiders
Recent insider trading involved Moran Kyle, Chief Financial Officer, that happened on Sep 25 ’24 when 17146.0 shares were sold. Officer, KYLE MORAN completed a deal on Sep 25 ’24 to buy 17146.0 shares. Meanwhile, President and CEO BOLNO PAUL sold 48366.0 shares on Aug 21 ’24.
